ADIL

Adial Pharmaceuticals, Inc.$2.70+0.05 (+1.89%)

Prev Close$2.65·MCap$1.7M·P/E—·Vol4.3K·Yield—

▲

Buys (12M)

$97.6K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$97.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Adial Pharmaceuticals, Inc. (ADIL) has been exclusively buying, with 2 insider purchases totaling $97.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by Coastlands Capital LP (10 percent owner), who purchased $32.6K worth of shares on Jul 13, 2026. Adial Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.7M.

ADIL Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 13, 2026	Coastlands Capital LP	10 percent owner	Buy	11,753	$2.78	$32.6K1.2% OS	385,075
Jul 1, 2026	Coastlands Capital LP	10 percent owner	Buy	25,000	$2.60	$65.0K2.6% OS	373,322
Sep 29, 2023	Schuyler Kevin	Director	Buy	700	$2.74	$1.9K	0
Dec 30, 2021	Newman James W. Jr.	Director	Buy	25,000	$2.69	$67.3K2.6% OS	0
Nov 29, 2021	Stilley William B. III	Chief Executive Officer	Buy	20,600	$2.67	$55.1K2.1% OS	0
Nov 26, 2021	Newman James W. Jr.	Director	Buy	10,000	$2.85	$28.5K1.0% OS	0
Apr 6, 2021	Johnson Bankole A.	Chief Medical Officer	Sell	150,000	$2.50	$375.0K15.6% OS	0

ADIL Insider Buying Activity

The following table shows recent insider purchases of Adial Pharmaceuticals, Inc. (ADIL) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 13, 2026	Coastlands Capital LP	10 percent owner	Buy	11,753	$2.78	$32.6K1.2% OS	385,075
Jul 1, 2026	Coastlands Capital LP	10 percent owner	Buy	25,000	$2.60	$65.0K2.6% OS	373,322
Sep 29, 2023	Schuyler Kevin	Director	Buy	700	$2.74	$1.9K	0
Dec 30, 2021	Newman James W. Jr.	Director	Buy	25,000	$2.69	$67.3K2.6% OS	0
Nov 29, 2021	Stilley William B. III	Chief Executive Officer	Buy	20,600	$2.67	$55.1K2.1% OS	0
Nov 26, 2021	Newman James W. Jr.	Director	Buy	10,000	$2.85	$28.5K1.0% OS	0